Recruitment is one of the biggest problems in clinical trials. Nearly 80% of clinical trials do not reach their enrollment goals on time. When this happens, the trials take longer and cost more. This makes it harder to get new treatments to patients quickly. Traditional recruitment depends mostly on people searching patient records manually, doctors referring patients, and outreach to communities. These methods take a lot of time and are often not very effective.<\/p>\n
<\/p>\n
It is also hard to recruit patients from diverse backgrounds. Groups like racial minorities and people living in rural areas have often been left out of clinical trials. This lack of diversity can make trial results less fair and less useful for everyone.<\/p>\n
<\/p>\n
Artificial intelligence (AI) uses computer programs to look at large sets of data and find patterns that humans might miss. For clinical trial recruitment, AI looks at electronic health records, genetic information, biomarkers, and sometimes social media data. This helps find people who may qualify for a trial.<\/p>\n
<\/p>\n
A study at the University of Texas showed that AI could find eligible patients for a cancer trial 70% faster than human recruiters. This speed helped the trial enroll patients 60% faster. Speeding up recruitment makes the whole trial move forward faster and patients can get results sooner.<\/p>\n
<\/p>\n
AI also lowers the number of screen failures. Screen failure happens when a patient does not meet the trial requirements after the initial check. For example, AI reduced screen failure rates in heart disease trials from 25% down to 10%. This makes recruitment more efficient.<\/p>\n
<\/p>\n
AI helps keep patients in trials longer too. Some diabetes trials using AI predictions had 80% of participants stay until the end. This reduces dropouts and helps collect better data.<\/p>\n
<\/p>\n
AI tools help target groups that are often underrepresented. One drug company using AI in a lung cancer trial saw a 35% increase in Hispanic and African American participants. This is important because it makes trial results applicable to more people and helps reduce health differences.<\/p>\n
<\/p>\n
By looking at demographics and social factors like education and marital status, AI can help find patients who might have been missed before or faced barriers to joining. This leads to a fairer recruitment process.<\/p>\n
<\/p>\n
Besides faster recruitment, AI provides real-time monitoring and data analysis to change recruitment plans quickly. For example, a global cancer trial used AI to watch enrollment at 50 sites. It helped find places where recruitment was slower and allowed teams to put in more effort there. This helped keep the trial on schedule.<\/p>\n
<\/p>\n
Decentralized trials, where patients visit and are monitored remotely, are becoming more common. AI supports these trials by gathering data from wearable devices and remote monitoring tools. This reduces the need for frequent clinic visits and makes it easier for patients in rural or underserved areas to join.<\/p>\n
\n<\/p>\n